Basic information
Biomarker: CA125 II
Histology type: endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Nagoya
Study type: Comparative Study
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 149 | EC | 10 | ovarian cancer | 59 | benign | 46 | cevical cancer | 14 |
Sample information
Conclusion: In conclusion, CA125 II is a better tumor marker than conventional CA125.
Sample type : serum
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
